HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion

Molecular Biology of the Cell

Volumn 16, Issue 2, 2005, Pages 550-561

  Khoury, Hanane ^a,b   Naujokas, Monica A ^b   Zuo, Dongmei ^b   Sangwan, Veena ^a,b   Frigault, Melanie M ^a,b   Petkiewicz, Stephanie ^a,b   Dankort, David L ^c   Muller, William J ^a,b   Park, Morag ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CLAUDIN 1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN ZO1; SCATTER FACTOR; UVOMORULIN;

ANIMAL CELL; ARTICLE; CELL DISRUPTION; CELL INVASION; CELL JUNCTION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIUM CELL; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANOIKIS; BLOTTING, WESTERN; CADHERINS; CELL LINE; CELL MOVEMENT; COLLAGEN; DOGS; DRUG COMBINATIONS; EPITHELIAL CELLS; EXTRACELLULAR MATRIX; GENES, ERBB-2; HEPATOCYTE GROWTH FACTOR; LAMININ; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; MORPHOGENESIS; PHOSPHOPROTEINS; PRECIPITIN TESTS; PROTEOGLYCANS; RECEPTOR, ERBB-2; TIGHT JUNCTIONS;

ANIMALIA;

EID: 12844262147     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E04-07-0567     Document Type: Article

References (69)

1. Andrechek, E. R., Hardy, W. R., Girgis-Gabardo, A. A., Perry, R. L., Butler, R., Graham, F. L., Kahn, R. C., Rudnicki, M. A., and Muller, W. J. (2002). ErbB2 is required for muscle spindle and myoblast cell survival. Mol. Cell. Biol. 22, 4714-4722.
2. Balda, M. S., and Matter, K. (2003). Epithelial cell adhesion and the regulation of gene expression. Trends Cell Biol. 13, 310-318.
3. Birchmeier, W., and Behrens, J. (1994). Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta 198, 11-26.
4. Bissell, M. J., Radisky, D. C., Rizki, A., Weaver, V. M., and Petersen, O. W. (2002). The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 70, 537-546.
5. Blanco, D., Vicent, S., Elizegi, E., Pino, I., Fraga, M. F., Esteller, M., Saffiotti, U., Lecanda, F., and Montuenga, L. M. (2004). Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis. Lab. Investig. 84, 999-1012.
6. Boyer, B., Valles, A. M., and Thiery, J. P. (1996). Model systems of epithelium-mesenchyme transitions. Acta Anat. 156, 227-239.
7. Brandt, B. H., et al. (1999). c-erbB-2/EGFR as dominant heterodimerization partners determine a motogenic phenotype in human breast cancer cells. FASEB J. 13, 1939-1949.
8. Chan, R., Hardy, W. R., Laing, M. A., Hardy, S. E., and Muller, W. J. (2002). The catalytic activity of the ErbB-2 receptor tyrosine kinase is essential for embryonic development. Mol. Cell. Biol. 22, 1073-1078.
9. Chausovsky, A., Tsarfaty, I., Kam, Z., Yarden, Y., Geiger, B., and Bershadsky, A. D. (1998). Morphogenetic effects of neuregulin (neu differentiation factor) in cultured epithelial cells. Mol. Biol. Cell 9, 3195-3209.
10. Chen, Y., Lu, Q., Schneeberger, E. E., and Goodenough, D. A. (2000). Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol. Biol. Cell 11, 849-862.
11. Dankort, D., Maslikowski, B., Warner, N., Kanno, N., Kim, H., Wang, Z., Moran, M. F., Oshima, R. G., Cardiff, R. D., and Muller, W. J. (2001). Grb2 and Shc adapter proteins play distinct roles in Neu (ErbB-2)-induced mammary tumorigenesis: implications for human breast cancer. Mol. Cell. Biol. 21, 1540-1551.
12. Dankort, D. L., Wang, Z., Blackmore, V., Moran, M. F., and Muller, W. J. (1997). Distinct tyrosine autophosphorylation sites negatively and positively modulate neu-mediated transformation. Mol. Cell. Biol. 17, 5410-5425.
13. Debnath, J., Mills, K. R., Collins, N. L., Reginato, M. J., Muthuswamy, S. K., and Brugge, J. S. (2002). The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111, 29-40.
14. Debnath, J., Muthuswamy, S. K., and Brugge, J. S. (2003). Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256-268.
15. Ebens, A., Brose, K., Leonardo, E. D., Hanson, M. G., Jr., Bladt, F., Birchmeier, C., Barres, B. A., and Tessier-Lavigne, M. (1996). Hepatocyte growth factor/ scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 17, 1157-1172.
16. Elliott, B. E., Hung, W. L., Boag, A. H., and Tuck, A. B. (2002). The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer. Can. J. Physiol. Pharmacol. 80, 91-102.
17. Fournier, T. M., Kamikura, D., Teng, K., and Park, M. (1996). Branching tubulogenesis but not scatter of Madin-Darby canine kidney cells requires a functional Grb2 binding site in the Met receptor tyrosine kinase. J. Biol. Chem. 271, 22211-22217.
18. Frisch, S. M. (2000). Anoikis. Methods Enzymol. 322, 472-479.
19. Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H. E., Behrens, J., Sommer, T., and Birchmeier, W. (2002). Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat. Cell Biol. 4, 222-231.
20. Ghoussoub, R. A., Dillon, D. A., D'Aquila, T., Rimm, E. B., Fearon, E. R., and Rimm, D. L. (1998). Expression of c-met is a strong independent prognostic factor in breast carcinoma. Cancer 82, 1513-1520.
21. Grande, M., Franzen, A., Karlsson, J. O., Ericson, L. E., Heldin, N. E., and Nilsson, M. (2002). Transforming growth factor-beta and EGF synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J. Cell Sci. 115, 4227-4236.
22. Guy, C. T., Cardiff, R. D., and Muller, W. J. (1996). Activated neu induces rapid tumor progression. J. Biol. Chem. 271, 7673-7678.
23. Guy, C. T., Webster, M. A., Schaller, M., Parsons, T. J., Cardiff, R. D., and Muller, W. J. (1992). Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89, 10578-10582.
24. Ikenouchi, J., Matsuda, M., Furuse, M., and Tsukita, S. (2003). Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J. Cell Sci. 116, 1959-1967.
25. Janda, E., Lehmann, K., Killisch, I., Jechlinger, M., Herzig, M., Downward, J., Beug, H., and Grunert, S. (2002). Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J. Cell Biol. 156, 299-313.
26. Ji, X., Woodard, A. S., Rimm, D. L., and Fearon, E. R. (1997). Transcriptional defects underlie loss of E-cadherin expression in breast cancer. Cell Growth Differ. 8, 773-778.
27. Jones, F. E., and Stern, D. F. (1999). Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation. Oncogene 18, 3481-3490.
28. Kang, J. Y., Dolled-Filhart, M., Ocal, I. T., Singh, B., Lin, C. Y., Dickson, R. B., Rimm, D. L., and Camp, R. L. (2003). Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. Cancer Res. 63, 1101-1105.
29. Khoury, H., Dankort, D. L., Sadekova, S., Naujokas, M. A., Muller, W. J., and Park, M. (2001). Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor. Oncogene 20, 788-799.
30. Khwaja, A., Lehmann, K., Marte, B. M., and Downward, J. (1998). Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway. J. Biol. Chem. 273, 18793-18801.
31. Kuperwasser, C., Chavarria, T., Wu, M., Magrane, G., Gray, J. W., Carey, L., Richardson, A., and Weinberg, R. A. (2004). Reconstruction of functionally normal and malignant human breast tissues in mice. Proc. Natl. Acad. Sci. USA 101, 4966-4971.
32. Lee, K. F., Simon, H., Chen, H., Bates, B., Hung, M. C., and Hauser, C. (1995). Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378, 394-398.
33. Leu, M., Bellmunt, E., Schwander, M., Farinas, I., Brenner, H. R., and Muller, U. (2003). Erbb2 regulates neuromuscular synapse formation and is essential for muscle spindle development. Development 130, 2291-2301.
34. Li, D., and Mrsny, R. J. (2000). Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin. J. Cell Biol. 148, 791-800.
35. Liang, C. C., and Chen, H. C. (2001). Sustained activation of extracellular signal-regulated kinase stimulated by hepatocyte growth factor leads to integrin alpha 2 expression that is involved in cell scattering. J. Biol. Chem. 276, 21146-21152.
36. Liebner, S., Fischmann, A., Rascher, G., Duffner, F., Grote, E. H., Kalbacher, H., and Wolburg, H. (2000). Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol. 100, 323-331.
37. Maroun, C. R., Holgado-Madruga, M., Royal, I., Naujokas, M. A., Fournier, T. M., Wong, A. J., and Park, M. (1999). The Gab1 PH domain is required for localization of Gabi at sites of cell-cell contact and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol. Cell. Biol. 19, 1784-1799.
38. McCawley, L. J., O'Brien, P., and Hudson, L. G. (1998). EGF- and scatter factor/hepatocyte growth factor (SF/HGF)-mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)-9. J. Cell Physiol. 176, 255-265.
39. Meiners, S., Brinkmann, V., Naundorf, H., and Birchmeier, W. (1998). Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene 16, 9-20.
40. Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., and Leder, P. (1988). Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54, 105-115.
41. Niemann, C., Brinkmann, V., Spitzer, E., Hartmann, G., Sachs, M., Naundorf, H., and Birchmeier, W. (1998). Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis. J. Cell Biol. 143, 533-545.
42. O'Brien, L. E., Tang, K., Kats, E. S., Schutz-Geschwender, A., Lipschutz, J. H., and Mostov, K. E. (2004). ERK and MMPs sequentially regulate distinct stages of epithelial tubule development. Dev. Cell 7, 21-32.
43. O'Brien, L. E., Zegers, M. M., and Mostov, K. E. (2002). Opinion: building epithelial architecture: insights from three-dimensional culture models. Nat. Rev. Mol. Cell. Biol. 3, 531-537.
44. Ohkubo, T., and Ozawa, M. (2004). The transcription factor Snail downregulates the tight junction components independently of E-cadherin downregulation. J. Cell Sci. 127, 1675-1685.
45. Ojakian, G. K., Nelson, W. J., and Beck, K. A. (1997). Mechanisms for de novo biogenesis of an apical membrane compartment in groups of simple epithelial cells surrounded by extracellular matrix. J. Cell Sci. 110, 2781-2794.
46. Pegram, M. D., Pauletti, G., and Slamon, D. J. (1998). HER-2/neu as a predictive marker of response to breast cancer therapy. Breast Cancer Res. Treat. 52, 65-77.
47. Pollack, A. L., Runyan, R. B., and Mostov, K. E. (1998). Morphogenetic mechanisms of epithelial tubulogenesis: MDCK cell polarity is transiently rearranged without loss of cell-cell contact during scatter factor/hepatocyte growth factor-induced tubulogenesis. Dev. Biol. 204, 64-79.
48. Potempa, S., and Ridley, A. J. (1998). Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol. Biol. Cell 9, 2185-2200.
49. Royal, I., Lamarche-Vane, N., Lamorte, L., Kaibuchi, K., and Park, M. (2000). Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation. Mol. Biol. Cell 11, 1709-1725.
50. Royal, I., and Park, M. (1995). Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J. Biol. Chem. 270, 27780-27787.
51. Savagner, P. (2001). Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23, 912-923.
52. Schmeichel, K. L., and Bissell, M. J. (2003). Modeling tissue-specific signaling and organ function in three dimensions. J. Cell Sci. 116, 2377-2388.
53. Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., and Birchmeier, C. (1995). Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373, 699-702.
54. Selli, C., Amorosi, A., Vona, G., Sestini, R., Travaglini, F., Bartoletti, R., and Orlando, C. (1997). Retrospective evaluation of c-erbB-2 oncogene amplification using competitive PCR in collecting duct carcinoma of the kidney. J. Urol. 158, 245-247.
55. Seton-Rogers, S. E., Lu, Y., Hines, L. M., Koundinya, M., LaBaer, J., Muthuswamy, S. K., and Brugge, J. S. (2004). Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proc. Natl. Acad. Sci. USA 101, 1257-1262.
56. Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J., and Massague, J. (2003). Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl. Acad. Sci. USA 100, 8430-8435.
57. Somasiri, A., and Roskelley, C. D. (1999). Cell shape and integrin signaling regulate the differentiation state of mammary epithelial cells. Methods Mol. Biol. 129, 271-283.
58. Tanimura, S., Nomura, K., Ozaki, K., Tsujimoto, M., Kondo, T., and Kohno, M. (2002). Prolonged nuclear retention of activated extracellular signal-regulated kinase 1/2 is required for hepatocyte growth factor-induced cell motility. J. Biol. Chem. 277, 28256-28264.
59. Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat Rev. Cancer 2, 442-454.
60. Tobioka, H., Isomura, H., Kokai, Y., Tokunaga, Y., Yamaguchi, J., and Sawada, N. (2004). Occludin expression decreases with the progression of human endometrial carcinoma. Hum. Pathol. 35, 159-164.
61. Tuck, A. B., Park, M., Sterns, E. E., Boag, A., and Elliott, B. E. (1996). Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am. J. Pathol. 148, 225-232.
62. Ueda, Y., Wang, S., Dumont, N., Yi, J. Y., Koh, Y., and Arteaga, C. L. (2004). Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility. J. Biol. Chem. 279, 24505-24513.
63. Uehara, Y., Minowa, O., Mori, C., Shiota, K., Kuno, J., Noda, T., and Kitamura, N. (1995). Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373, 702-705.
64. Weidner, K. M., Hartmann, G., Sachs, M., and Birchmeier, W. (1993). Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met. Am. J. Respir. Cell. Mol. Biol. 8, 229-237.
65. Wrobel, C. N., Debnath, J., Lin, E., Beausoleil, S., Roussel, M. F., and Brugge, J. S. (2004). Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture. J. Cell Biol. 165, 263-273.
66. Yamashita, J., Ogawa, M., Yamashita, S., Nomura, K., Kuramoto, M., Saishoji, T., and Shin, S. (1994). Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res. 54, 1630-1633.
67. Yang, Y., Spitzer, E., Meyer, D., Sachs, M., Niemann, C., Hartmann, G., Weidner, K. M., Birchmeier, C., and Birchmeier, W. (1995). Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol. 131, 215-226.
68. Zhang, G. J., Tsuda, H., Adachi, I., Fukutomi, T., Yamamoto, H., and Hirohashi, S. (1997). Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins. Jpn. J. Clin. Oncol. 27, 371-377.
69. Zhu, H., Naujokas, M. A., and Park, M. (1994). Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor. Cell Growth Differ. 5, 359-366.